**Epigenetics in Cancer: The Myelodysplastic Syndrome as a Model to Study Epigenetic Alterations as Diagnostic and Prognostic Biomarkers**

Teresa de Souza Fernandez1, André Mencalha1 and Cecília de Souza Fernandez2 *1National Cancer Institute (INCA), Bone Marrow Transplantation Center (CEMO) Laboratory Division, Rio de Janeiro, RJ, 2Mathematics and Statistics Institute, Federal Fluminense University (UFF), Niterói, RJ, Brazil* 
